Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml
Product details
Registration number: SIN13902P
Classification: Prescription Only
Active ingredients: Idursulfase
Strength: 6.0 mg/vial
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
ATC code: A16AB09
HSA approval date: 24 December 2010
Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co. KG (fill-finish)
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13902P
Classification: Prescription Only
What active ingredients and strength are recorded for Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Idursulfase
Strength: 6.0 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml?
According to the HSA dataset updated 7 August 2026:
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co. KG (fill-finish)
Manufacturing country/countries: GERMANY
Where can I look up Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13902P or the exact product name Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml. The general register link does not preselect this product.
What are the source dates for this Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Elaprase (TM) Solution for Intravenous Infusion 2mg/ ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13902P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)